Anhui Guangxin Agrochemical (603599)
- 10.16
- -0.13-1.26%
Anhui Guangxin Agrochemical (603599) News
Huaan Securities: Focus on supply-side segments with strong constraints and demand-side opportunities driven by emerging applications as the two key themes.
The bank recommends focusing on two investment themes with relatively high certainty: on the supply side, prioritize products subject to strong constraints; on the demand side, explore emerging applications with high growth potential.
Research Report Insights | Huajin Securities: Maintains "Buy" rating on Guangxin Shares, noting improved profitability in Q1
A research report by Huaan Securities noted that Guangxin Co., Ltd.'s net profit attributable to owners of the parent for the full year 2025 is RMB 657 million, a 15.64% year-on-year decrease; for the first quarter of 2026, net profit attributable to owners of the parent was RMB 157 million, down 2.27% year-on-year but up 15.28% quarter-on-quarter. Prices of core products have rebounded, leading to an improvement in profitability in the first quarter. As of May 18, the average market prices in Q2 for p-nitrochlorobenzene, o-nitrochlorobenzene, diuron, and glyphosate increased by 105.40%, 28.22%, 18.91%, and 36.05% quarter-on-quarter, respectively, which is expected to further boost profitability.
Guangxin Co., Ltd. (603599): Rising market conditions for ortho/para-nitrochlorobenzene likely to drive sustained earnings improvement
Event Description: On April 27, the company released its 2025 annual report and Q1 2026 report. For the full year 2025, the company recorded revenue of RMB 3.532 billion, a year-over-year decrease of 23.92%; net profit attributable to owners of the parent company was
Guangxin Co., Ltd. (603599): Recovery in the pesticide industry boosts profitability, with significant improvement in earnings from ortho-nitro products.
The company released its 2025 annual report: During the reporting period, the company achieved revenue of 3.532 billion yuan (YoY -24%), net profit attributable to shareholders of 657 million yuan (YoY -16%), and non-recurring net profit of 509 million yuan (YoY -
Guangxin Co., Ltd. (603599): Performance in line with expectations; o-nitrobenzene business is expected to see improvement.
Key insights for 2025 indicate that Guangxin Co., Ltd. experienced temporary performance pressure due to the impact of glyphosate technical upgrades on production output, and this trend continued into early 2026. Pesticide prices remain in a bottom range, while surging oil prices are expected to trigger agricultural product inflation, impacting agrochemicals.
Express News | Stock Market Risk Alert for May 6
Kelan Software and S Jiatong have been investigated by the CSRC for suspected violations of information disclosure regulations.
①Coland Software and S Jiatong successively announced that they have been investigated by the CSRC due to suspected violations of information disclosure regulations. ③Guangxin Co., Ltd. announced that its controlling shareholder has been investigated by the CSRC for suspected violations of information disclosure regulations related to changes in shareholding.
Express News | Guangxin Co., Ltd.: The controlling shareholder, Guangxin Group, has been investigated for alleged violations and illegal activities related to the disclosure of shareholding changes.
Guangxin Co., Ltd. (603599): Price increase of ortho/para-nitrochlorobenzene may boost company performance.
Guangxin Co., Ltd. released its annual report for 2025 and the first quarter report for 2026: In 2025, it achieved revenue of 3.532 billion yuan (yoy -24%), net profit attributable to shareholders of 657 million yuan (yoy -16%), and non-recurring net profit of 509 million yuan.
Guangxin Co., Ltd. reported revenue of 35.32 billion yuan in 2025, a year-on-year decrease of 23.92%, and a net profit attributable to shareholders of 6.57 billion yuan, representing a year-on-year decline of 15.64%.
In 2025, the company's revenue and net profit both declined, with a more pronounced drop in non-GAAP net profit, primarily due to support from non-recurring gains; gross margin improved to 32.92%, benefiting from better margins in pesticides and overseas operations, but revenue contraction led to a corresponding decline in cash flow. Pesticides and intermediates served as dual pillars, with significant improvement in overseas gross margin, shifting the profit center abroad; R&D and sales expenses decreased alongside scaled-back operations, dividend payout ratio was approximately 30.5%, and control remained stable.
Guangxin Co., Ltd. (603599): Significant improvement in profitability of nitrochlorobenzene and ortho-nitrochlorobenzene
The 2025 financial performance met market expectations, and the core operating results for the first quarter of 2026 also aligned with market projections. Guangxin Co., Ltd. announced its 2025 financial results, reporting revenue of 3.532 billion yuan, a year-over-year decrease of 23.92%; net profit attributable to shareholders was 657 million yuan.
Guangxin Co., Ltd.: 2025 Annual Report
Guangxin Co., Ltd.: First Quarter Report for 2026
Guangxin Co., Ltd.: Summary of the 2025 Annual Report
Summary of the 2025 Annual Report
First Quarter Report for 2026
Announcement of Key Operating Data for Fiscal Year 2025
Announcement of Key Operating Data for the First Quarter of 2026
Annual Report 2025
Guangxin Co., Ltd. (603599.SH) announced its first-quarter financial results, with a net profit attributable to shareholders of 157 million yuan, representing a year-on-year decrease of 2.27%.
Guangxin Co., Ltd. (603599.SH) disclosed its Q1 2026 report, showing revenue of 912 million yuan, a year-on-year decrease of 7.14%; net profit attributable to shareholders of 157 million yuan, down 2.27% year-on-year; non-recurring net profit of 132 million yuan, up 4.98% year-on-year. Basic earnings per share were 0.17 yuan.